Abstract

Poor performance in the 6-min walk test (6MWT < 350 m) is an important prognostic indicator of mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Little is known about the stability of this state over time and what factors might predict a poor 6MWT performance. To determine the stability of 6MWT performance over a 2-year period in COPD patients participating in annual medical follow-up visits, and to assess the ability of several clinical, pulmonary, and non-pulmonary factors to predict poor 6MWT performance, we prospectively included 137 patients with stable COPD (mean age, 66.9 ± 8.3 years). The 6MWT was scored at baseline and 2-year follow-up. To evaluate clinical, pulmonary, and non-pulmonary variables as potential predictors of poor 6MWT performance, we used multiple logistic regression models adjusted for age, sex, weight, height, and 6MWT performance at baseline. Poor 6MWT performance was stable over 2 years for 67.4% of patients. Predictors of poor 6MWT performance included a five-repetition sit-to-stand test score ≤2 (OR, 3.01; 95% CI, 1.22–7.42), the percentage of mobility activities with limitations (OR, 1.03; 95% CI, 1.00–1.07), and poor 6MWT performance at baseline (OR, 4.64; 95% CI, 1.88–11.43). Poor 6MWT performance status was stable for the majority of COPD patients. Lower scores on the five-repetition sit-to-stand test and a higher number of mobility activities with limitations were relevant predictors of poor 6MWT performance over 2 years. Prognostic models based on these non-pulmonary factors can provide non-inferior discriminative ability in comparison with prognostic models based on only pulmonary factors.

Highlights

  • The 6-min walk test (6MWT) is the most popular test to measure exercise tolerance in patients with chronic obstructive pulmonary disease (COPD) [1,2]

  • We primarily examined the stability of 6MWT performance over a 2-year period and evaluated predictors of poor 6MWT performance in stable COPD patients who participated in annual medical follow-up visits

  • Regarding the 2-year temporal evolution of the mean scores of non-pulmonary factors, our results showed that patients with stable and with unstable 6MWT performance showed a similar evolution of five-repetition sit-to-stand test (5STS) test results and limited mobility activities

Read more

Summary

Introduction

The 6-min walk test (6MWT) is the most popular test to measure exercise tolerance in patients with chronic obstructive pulmonary disease (COPD) [1,2]. Impaired exercise tolerance is an important indicator of severity in COPD [6] and has previously been associated with decreased functional capacity to perform activities of daily living, as well as with a reduction in the quality of life [7,8]. Poor 6MWT performance (walking distances < 350 m) has been associated with a significant increase in mortality and a high risk of exacerbation [9,10]. Given the importance of impaired exercise tolerance and poor 6MWT performance (

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call